Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s11605-020-04832-y.pdf
Reference33 articles.
1. San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I. Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors. JAMA Intern Med. 2019;179(5):713–6. https://doi.org/10.1001/jamainternmed.2018.7656.
2. Armuzzi A, DiBonaventura MD, Tarallo M, Lucas J, Bluff D, Hoskin B et al. Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe. PLoS One. 2020;15(1):e0227914. https://doi.org/10.1371/journal.pone.0227914.
3. Targownik LE, Tennakoon A, Leung S, Lix LM, Singh H, Bernstein CN. Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis. Clin Gastroenterol Hepatol. 2017;15(7):1061–70 e1. https://doi.org/10.1016/j.cgh.2017.01.035.
4. Carter MJ, Lobo AJ, Travis SP, Ibd Section BSoG. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53 Suppl 5:V1–16. https://doi.org/10.1136/gut.2004.043372.
5. Andrews HA, Lewis P, Allan RN. Prognosis after surgery for colonic Crohn’s disease. Br J Surg. 1989;76(11):1184–90. https://doi.org/10.1002/bjs.1800761123.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of filgotinib in ulcerative colitis and Crohn’s disease;Immunotherapy;2024-02
2. Treatment persistence and switching patterns of ABP 501 in European patients with inflammatory bowel disease;Therapeutic Advances in Gastroenterology;2024-01
3. Inflammatory bowel diseases: Transformation of representations. A review;Terapevticheskii arkhiv;2023-12-28
4. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease;Gastroenterology;2023-12
5. Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London;Expert Opinion on Biological Therapy;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3